Clinical Trial Update: Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating intravenous administration of RGI-2001 for graft-versus-host disease in patients undergoing allogenic hematopoietic stem …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• RGI-2001

Snippet

Sponsor: Regimmune Corporation | Conditions: Graft Versus Host Disease | Phase 1, Phase 2 | Status: COMPLETED